Supriya Lifescience achieves GMP certification from ANVISA for Lote Parshuram site

Supriya Lifescience Limited, a global leader in the manufacturing of Active Pharmaceutical Ingredients (APIs), has recently marked a significant milestone in its commitment to high-quality standards. The company proudly announced that its manufacturing site in Lote Parshuram has received Good Manufacturing Practice (GMP) certification from the Regulatory Authority of Brazil, ANVISA. This achievement highlights Supriya Lifescience’s dedication to excellence in smart manufacturing practices.

The Lote Factory of Supriya Lifescience Limited passed the Brazilian Good Manufacturing Practice (GMP) inspection with an exceptional “Zero” Observation in terms of Compliance. This flawless performance in the rigorous GMP inspection is a testament to the company’s adherence to the highest quality standards in pharmaceutical manufacturing.

The clearance of this audit by ANVISA is not only a significant achievement for Supriya Lifescience Ltd. but also marks the successful registration of 8 APIs with CADIFA. This accomplishment will facilitate smoother and faster registration of the company’s other APIs, expanding its footprint in the global pharmaceutical market.

Supriya Lifescience Ltd’s Manufacturing Site in Lote Parshuram Receives Prestigious GMP Certification from Brazil’s ANVISA

Brazil’s GMP review process is known for its stringent requirements and comprehensive on-site inspections, focusing on pharmaceutical quality management, data integrity, manufacturing facilities, and compliance with GMP in production processes. Passing Brazil’s GMP without any issues is widely recognized as a challenging feat in the industry, and achieving a flawless inspection is a remarkable accomplishment.

Established in 1987, Supriya Lifescience Ltd. has been at the forefront of pharmaceutical innovation and quality. The company’s state-of-the-art facility in Khed, District Ratnagiri, is also certified by various international regulatory authorities, including the USFDA, EDQM, EUGMP, NMPA, and Health Canada. With its headquarters in Mumbai, India, Supriya Lifescience Ltd. continues to set high standards in the global pharmaceutical industry.

This latest certification by ANVISA reinforces Supriya Lifescience Ltd.’s position as a reputable and reliable player in the pharmaceutical sector, committed to delivering quality and excellence in its products and manufacturing practices.